Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Gotto GT, Yip SM, Shayegan B, O'Sullivan DE, Wallis CJD, Basappa NS, Cagiannos I, Hamilton RJ, Ferrario C, Fernandes R, Danielson B, Saad F, Hotte SJ, Cheung WY, Boyne DJ, Chan K, Osborne B, Zardan A, Malone S. Gotto GT, et al. Among authors: fernandes r. Can Urol Assoc J. 2024 Aug 30. doi: 10.5489/cuaj.8691. Online ahead of print. Can Urol Assoc J. 2024. PMID: 39470659 Free article.
Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers.
Saad F, Hotte SJ, Finelli A, Malone S, Niazi T, Noonan K, Shayegan B, So AI, Danielson B, Basappa NS, Cagiannos I, Canil C, Delouya G, Fernandes R, Ferrario C, Gotto GT, Hamilton RJ, Izard JP, Kapoor A, Khalaf D, Kolinsky M, Lalani AK, Lavallée LT, Morash C, Morgan SC, Ong M, Pouliot F, Rendon RA, Yip S, Zardan A, Park-Wyllie L, Chi K. Saad F, et al. Among authors: fernandes r. Can Urol Assoc J. 2021 Oct;15(10):353-358. doi: 10.5489/cuaj.7347. Can Urol Assoc J. 2021. PMID: 34125066 Free PMC article. Review.
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada.
Wallis CJD, Shayegan B, Morgan SC, Hamilton RJ, Cagiannos I, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Chan KFY, Park-Wyllie L, Malone S. Wallis CJD, et al. Among authors: fernandes r. Cancers (Basel). 2021 Jun 7;13(11):2844. doi: 10.3390/cancers13112844. Cancers (Basel). 2021. PMID: 34200349 Free PMC article.
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer.
Wallis CJD, Malone S, Cagiannos I, Morgan SC, Hamilton RJ, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Niazi T, Noonan KL, Saad F, Hotte SJ, Hew H, Chan KFY, Wyllie LP, Shayegan B. Wallis CJD, et al. Among authors: fernandes r. JNCI Cancer Spectr. 2021 Oct 1;5(6):pkab082. doi: 10.1093/jncics/pkab082. eCollection 2021 Dec. JNCI Cancer Spectr. 2021. PMID: 34926988 Free PMC article.
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada.
Shayegan B, Wallis CJD, Hamilton RJ, Morgan SC, Cagiannos I, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Park-Wyllie L, Chan KFY, Malone S. Shayegan B, et al. Among authors: fernandes r. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):74-79. doi: 10.1038/s41391-022-00514-9. Epub 2022 Feb 23. Prostate Cancer Prostatic Dis. 2023. PMID: 35197558
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada.
Shayegan B, Wallis CJD, Malone S, Cagiannos I, Hamilton RJ, Ferrario C, Gotto GT, Basappa NS, Morgan SC, Fernandes R, Morash C, Niazi T, Noonan KL, Rendon R, Osborne B, Park-Wyllie L, Chan KFY, Hotte SJ, Saad F. Shayegan B, et al. Among authors: fernandes r. Urol Oncol. 2022 May;40(5):192.e1-192.e9. doi: 10.1016/j.urolonc.2022.01.009. Epub 2022 Feb 23. Urol Oncol. 2022. PMID: 35216890 Free article.
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study.
Malone S, Wallis CJD, Lee-Ying R, Basappa NS, Cagiannos I, Hamilton RJ, Fernandes R, Ferrario C, Gotto GT, Morgan SC, Morash C, Niazi T, Noonan KL, Rendon R, Hotte SJ, Saad F, Zardan A, Osborne B, Chan KFY, Shayegan B. Malone S, et al. Among authors: fernandes r. BJUI Compass. 2022 May 18;3(5):383-391. doi: 10.1002/bco2.158. eCollection 2022 Sep. BJUI Compass. 2022. PMID: 35950037 Free PMC article.
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.
Fleshner NE, Sayyid RK, Hansen AR, Chin JLK, Fernandes R, Winquist E, van der Kwast T, Sweet J, Lajkosz K, Kenk M, Hersey K, Veloso R, Berlin D, Herrera-Caceres JO, Sridhar S, Moussa M, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Joshua AM. Fleshner NE, et al. Among authors: fernandes r. Clin Cancer Res. 2023 Oct 2;29(19):3867-3874. doi: 10.1158/1078-0432.CCR-23-0731. Clin Cancer Res. 2023. PMID: 37439809 Clinical Trial.
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Saad F, Hotte SJ, Noonan K, Malone S, Morash C, Niazi T, Rendon RA, Shayegan B, Basappa NS, Cagiannos I, Danielson B, Delouya G, Fernandes R, Ferrario C, Finelli A, Gotto GT, Hamilton RJ, Izard JP, Kapoor A, Lalani AK, Lavallée LT, Ong M, Pouliot F, So AI, Yip S, Chi KN. Saad F, et al. Among authors: fernandes r. Can Urol Assoc J. 2024 Apr;18(4):E127-E137. doi: 10.5489/cuaj.8537. Can Urol Assoc J. 2024. PMID: 38381937 Free PMC article.
2,638 results